I am/have/had
I am looking for
Advanced Filters
Found 301 clinical trials
A Trial of Neoadjuvant mXELOXIRI Versus CRT in the EMVI Positive LARC
The study is to evaluate the efficacy and safety of XELOXIRI as neoadjuvant chemotherapy alone for EMVI+ LARC in contrast to the efficacy of standard Chemoradiotherapy (CRT).
cancer
adenocarcinoma
platelet count
renal function
rectal carcinoma
- 0 views
- 19 Feb, 2024
- 1 location